Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Amid feud with OpenAI CEO Sam Altman over the $500 billion Stargate AI project, Elon Musk seems to have found an unlikely ...
Filed in a Missouri court, the lawsuit accuses Sam of abuse spanning nearly a decade, a claim his family has categorically ...